CAV2 had specific diagnostic significance in the area under the pancreatic cancer-specific ROC curve of 0.927 (e.g., Fig. 1B), and the pancreatic cancer group with high CAV2 expression showed worse survival when compared to the low expression group (e.g., Fig. 1C). This evidence concerns the gene CAV2 and familial pancreatic carcinoma.